Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research

被引：48
作者：
Ioannidis, John P. A. [1 ,2 ,3 ,4 ]
机构：
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Stat, Sch Humanities & Sci, Stanford, CA 94305 USA
[4] Metares Innovat Ctr Stanford METR, Stanford, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2017年 / 317卷 / 10期
关键词：
D O I：
10.1001/jama.2017.0549
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1019 / 1020
页数：2
相关论文
共 6 条
  • [1] Raise standards for preclinical cancer research
    Begley, C. Glenn
    Ellis, Lee M.
    [J]. NATURE, 2012, 483 (7391) : 531 - 533
  • [2] An open investigation of the reproducibility of cancer biology research
    Errington, Timothy M.
    Iorns, Elizabeth
    Gunn, William
    Tan, Fraser Elisabeth
    Lomax, Joelle
    Nosek, Brian A.
    [J]. ELIFE, 2014, 3
  • [3] What does research reproducibility mean?
    Goodman, Steven N.
    Fanelli, Daniele
    Ioannidis, John P. A.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (341)
  • [4] Why Most Clinical Research Is Not Useful
    Ioannidis, John P. A.
    [J]. PLOS MEDICINE, 2016, 13 (06):
  • [5] Reproducibility in Cancer Biology: Making sense of replications
    Nosek, Brian A.
    Errington, Timothy M.
    [J]. ELIFE, 2017, 6
  • [6] Believe it or not: how much can we rely on published data on potential drug targets?
    Prinz, Florian
    Schlange, Thomas
    Asadullah, Khusru
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (09) : 712 - U81
1